Task Force Recommends Chemical Castration, Legal Reforms to Curb Femicide in Kenya
The alarming rise in gender-based violence (GBV) and femicide in Kenya has prompted bold proposals from a presidential task force, including the controversial recommendation of chemical castration for certain convicted sex offenders.
Presented to President William Ruto on January 26, 2026, the report from the Technical Working Group on Gender-Based Violence Including Femicide—chaired by former Deputy Chief Justice Nancy Baraza—highlights systemic failures and urges sweeping reforms. While the measures aim to curb a national crisis, they raise profound ethical, medical, legal, and financial questions.
Surge in Femicide Sparks National Outcry
Kenya recorded a devastating spike in femicide in 2024, with at least 170 women murdered—the highest annual figure on record and a 79% increase from 95 cases in 2023. From September to November 2024 alone, authorities documented 97 cases, averaging one woman killed per day. The Nairobi Women’s Hospital Gender Violence Recovery Center handled around 4,000 GBV cases monthly, underscoring the epidemic’s scale.
Public anger boiled over into protests, with activists blaming entrenched misogyny, weak laws, and delayed justice. In response, President Ruto formed the 42-member task force in January 2025 to investigate trends, gaps, and solutions through nationwide consultations across all 47 counties.
Task Force Report: Key Findings on Violence Patterns
Analyzing over 930 female murders since 2016 from court records and media, the report reveals persistent patterns. Intimate partners (husbands or boyfriends) account for 70% of convictions in 2024. Young women aged 18–35 face the highest risk, comprising over half of victims, while suspects are predominantly young men in the same age group.
Justice remains slow: Cases take an average of 4.01 years from filing to verdict. Convictions rose 118% in 2024 compared to the prior year, with average sentences increasing from 20 to 23 years. Yet, inconsistencies in sentencing fuel perceptions of leniency.
The report identifies broader gaps: under-reporting, weak data systems, patriarchal norms, and inadequate institutional support leave women vulnerable at home and in communities.
Recommendation: Chemical Castration for Repeat Sex Offenders
A headline proposal calls for amending the Sexual Offences Act, 2006, to introduce chemical castration—mandatory for offenders convicted of defilement of children or persons with disabilities, and potentially repeat rapists. The measure targets both male and female offenders to reduce recidivism by suppressing libido through hormone-blocking drugs (e.g., Goserelin or Leuprolide).
Proponents argue it is “reversible” (unlike surgical castration) and effective while administered, drawing from practices in countries like South Korea (since 2011 for child molesters), Pakistan (2021), Ukraine (2019), and several U.S. states (California, Florida, Iowa, among others). In some jurisdictions, it has faced criticism from groups like Amnesty International for being “cruel and inhuman.”
What Chemical Castration Entails and Its Effects
Chemical castration uses medications to suppress sex hormone production (testosterone in men; estrogen/testosterone in women), lowering sexual drive and activity. Originally developed for hormone-dependent cancers like prostate or breast cancer, it induces:
- In men: Reduced libido, erectile dysfunction, testicular/penile shrinkage, infertility, breast tissue growth, hot flashes, bone density loss (osteoporosis risk), cardiovascular issues, weight gain, depression, and mood swings.
- In women: Libido drop, menopause-like symptoms (vaginal thinning, breast changes), osteoporosis, anemia, heart risks, and emotional distress.
Effects are largely reversible upon stopping treatment, but long-term use carries irreversible risks. Experts like Dr. Wahome Ngare emphasize it does not address underlying psychological or moral issues—often rooted in trauma—and should pair with therapy. Fr. Conor, a priest and doctor, highlights human dignity concerns, unintended side effects, and questions restitution if convictions are overturned on appeal.
Practical Challenges: Costs and Implementation in Kenya
Medications cost Ksh.9,000–39,000 per injection, requiring ongoing doses. In a resource-strained economy, questions arise: Would the government fund this for inmates over education, health, or infrastructure? Many prisoners rely on family for basic drugs—prioritizing castration drugs could strain budgets further.
Broader Reforms Proposed by the Task Force
Beyond chemical castration, the report urges:
- Recognizing femicide as a distinct crime in the Penal Code for better tracking and accountability.
- Removing judicial discretion for mandatory minimum sentences in aggravated sexual offences.
- Banning out-of-court settlements in GBV cases to ensure prosecution.
- Declaring GBV and femicide a national crisis to prioritize resources, coordination, and awareness.
- Establishing dedicated funding (e.g., a proposed Sh50 billion GBV fund) and improved data systems.
These aim to restore public trust in justice and tackle root causes.
Ethical and Human Rights Dilemmas
While the crisis demands action, critics warn chemical castration risks violating dignity, medical ethics, and rights—even for convicts. It treats symptoms rather than causes, potentially polarizing society. Human rights advocates question its proportionality, reversibility in practice, and application to women.
The proposals now await parliamentary debate and constitutional review. If enacted, they could reshape sentencing for sexual crimes, but success depends on balancing punishment with rehabilitation, prevention, and survivor support. As Kenya confronts this scourge, the path forward requires careful scrutiny to protect women and girls without compromising core principles of justice and humanity.
Also Read: Ruto Sends Message to Police After Othaya Church Incident involving Gachagua
Task Force Recommends Chemical Castration, Legal Reforms to Curb Femicide in Kenya